Building blocks in place for LiDCO's move into profit
This article was originally published in Clinica
2005 will be our last year of losses." So said Terry O'Brien, CEO of London, UK-based cardiovascular monitoring company LiDCO, in an interview with Clinica following the announcement of 2004 results showing a net loss of £4.2m ($7.9m) on turnover of £2.5m.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.